ATE299739T1 - Neurokinin b vorläufer aus menschlicher plazenta - Google Patents

Neurokinin b vorläufer aus menschlicher plazenta

Info

Publication number
ATE299739T1
ATE299739T1 AT00974680T AT00974680T ATE299739T1 AT E299739 T1 ATE299739 T1 AT E299739T1 AT 00974680 T AT00974680 T AT 00974680T AT 00974680 T AT00974680 T AT 00974680T AT E299739 T1 ATE299739 T1 AT E299739T1
Authority
AT
Austria
Prior art keywords
neurokinin
precursor
methods
human placenta
eclampsia
Prior art date
Application number
AT00974680T
Other languages
English (en)
Inventor
Nigel Page
Phillip Lowry
Original Assignee
Univ Reading
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Reading filed Critical Univ Reading
Application granted granted Critical
Publication of ATE299739T1 publication Critical patent/ATE299739T1/de

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/689—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to pregnancy or the gonads
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/046—Tachykinins, e.g. eledoisins, substance P; Related peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/74—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving hormones or other non-cytokine intercellular protein regulatory factors such as growth factors, including receptors to hormones and growth factors
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2410/00—Assays, e.g. immunoassays or enzyme assays, involving peptides of less than 20 animo acids
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/36—Gynecology or obstetrics
    • G01N2800/368—Pregnancy complicated by disease or abnormalities of pregnancy, e.g. preeclampsia, preterm labour

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Analytical Chemistry (AREA)
  • Pathology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Physics & Mathematics (AREA)
  • Biotechnology (AREA)
  • Cell Biology (AREA)
  • Biochemistry (AREA)
  • Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Food Science & Technology (AREA)
  • Reproductive Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Endocrinology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Pregnancy & Childbirth (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Epidemiology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
AT00974680T 1999-11-16 2000-11-10 Neurokinin b vorläufer aus menschlicher plazenta ATE299739T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9927125.6A GB9927125D0 (en) 1999-11-16 1999-11-16 Placental human neurokinin B precursor
PCT/GB2000/004315 WO2001036979A2 (en) 1999-11-16 2000-11-10 Placental human neurokinin b precursor

Publications (1)

Publication Number Publication Date
ATE299739T1 true ATE299739T1 (de) 2005-08-15

Family

ID=10864633

Family Applications (1)

Application Number Title Priority Date Filing Date
AT00974680T ATE299739T1 (de) 1999-11-16 2000-11-10 Neurokinin b vorläufer aus menschlicher plazenta

Country Status (15)

Country Link
US (1) US7947458B1 (de)
EP (1) EP1229965B1 (de)
JP (1) JP4668501B2 (de)
CN (1) CN1414871A (de)
AT (1) ATE299739T1 (de)
AU (1) AU778423B2 (de)
CA (1) CA2391531A1 (de)
DE (1) DE60021409T2 (de)
ES (1) ES2244480T3 (de)
GB (1) GB9927125D0 (de)
IL (1) IL149598A0 (de)
NO (1) NO330412B1 (de)
NZ (1) NZ519283A (de)
WO (1) WO2001036979A2 (de)
ZA (1) ZA200203880B (de)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6919433B2 (en) 1997-03-14 2005-07-19 Human Genome Sciences, Inc. Antibodies to protein HPMBQ91
EP1333092A3 (de) * 1997-03-14 2003-12-10 Human Genome Sciences, Inc. 28 menschlich sekretierte Proteine
US20240336565A1 (en) 2021-07-02 2024-10-10 Acer Therapeutics, Inc. Solid forms of osanetant

Family Cites Families (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4742156A (en) * 1985-09-30 1988-05-03 Mcneilab, Inc. Peptide antagonists of neurokinin B and opthalmic solutions containing them
US4665157A (en) 1985-09-30 1987-05-12 Mcneilab, Inc. Peptide antagonists of neurokinin B
US5331089A (en) 1988-03-25 1994-07-19 Merck Sharpe & Dohme, Ltd. Peptides useful as tachykinin agonists
US5079171A (en) * 1988-09-15 1992-01-07 Adeza Biomedical Corporation Determining pregnancy induced hypertension and eclampsia by immunoassay of cellular fibronectin
AU687754B2 (en) 1990-08-31 1998-03-05 Warner-Lambert Company Tachykinin antagonists
DE69231395T3 (de) 1991-09-20 2005-07-21 Glaxo Group Ltd., Greenford Neue medizinische Indikation für Tachykinin-Antagonisten
US5328927A (en) 1992-03-03 1994-07-12 Merck Sharpe & Dohme, Ltd. Hetercyclic compounds, processes for their preparation and pharmaceutical compositions containing them
WO1994001402A1 (en) 1992-07-13 1994-01-20 Merck Sharp & Dohme Limited Heterocyclic amide derivatives as tachykinin derivatives
US5922681A (en) * 1992-09-14 1999-07-13 Warner-Lambert Company Endothelin antagonists
FR2696178B1 (fr) 1992-09-30 1994-12-30 Sanofi Elf Amides basiques quaternaires, procédé pour leur préparation et compositions pharmaceutiques en contenant.
US5344830A (en) 1992-12-10 1994-09-06 Merck & Co., Inc. N,N-diacylpiperazine tachykinin antagonists
US5543138A (en) * 1994-03-10 1996-08-06 Genetics Institute, Inc. Methods of diagnosing and treating preeclampsia
FR2719311B1 (fr) * 1994-03-18 1998-06-26 Sanofi Sa Composés antagonistes sélectifs du récepteur NK3 humain et leur utilisation comme médicaments et outils de diagnostic.
US5491140A (en) 1994-06-30 1996-02-13 Eli Lilly And Company Naphthyl tachykinin receptor antagonists to treat physiological conditions
WO1996001819A1 (en) 1994-07-12 1996-01-25 Eli Lilly And Company Heterocyclic tachykinin receptor antagonists
CA2154116A1 (en) 1994-07-22 1996-01-23 Philip Arthur Hipskind 1-aryl-2-acetamidopentanone derivatives for use as tachykinin receptor antagonists
WO1997044035A1 (en) * 1996-05-24 1997-11-27 Eli Lilly And Company Methods of treating hypertension
GB9618931D0 (en) * 1996-09-11 1996-10-23 Univ London Inositol phosphoglycans for therapeutic use in pre-eclampsia and diabetes
US5846973A (en) 1997-05-23 1998-12-08 Eli Lilly And Company Methods of treating pulmonary hypertension
US5985606A (en) * 1997-06-19 1999-11-16 Incyte Pharmaceuticals, Inc. Human preprotachykinin B
CA2236489A1 (en) * 1997-07-14 1999-01-14 Human Genome Sciences Novel compounds
EP0892053A3 (de) * 1997-07-14 1999-12-29 Smithkline Beecham Plc Herstellung von rekombinantem HPMBQ91 Polypeptide und dessen Verwendungen
US6689566B1 (en) * 1999-01-14 2004-02-10 Scantibodies Laboratory, Inc. Methods, kits, and antibodies for detecting parathyroid hormone

Also Published As

Publication number Publication date
WO2001036979A3 (en) 2002-05-02
NO330412B1 (no) 2011-04-11
IL149598A0 (en) 2002-11-10
EP1229965A2 (de) 2002-08-14
DE60021409D1 (de) 2005-08-25
WO2001036979A2 (en) 2001-05-25
NO20022276D0 (no) 2002-05-14
NO20022276L (no) 2002-07-05
AU778423B2 (en) 2004-12-02
CN1414871A (zh) 2003-04-30
CA2391531A1 (en) 2001-05-25
US7947458B1 (en) 2011-05-24
ZA200203880B (en) 2003-08-15
GB9927125D0 (en) 2000-01-12
AU1289801A (en) 2001-05-30
DE60021409T2 (de) 2006-05-24
JP2003515138A (ja) 2003-04-22
JP4668501B2 (ja) 2011-04-13
ES2244480T3 (es) 2005-12-16
NZ519283A (en) 2004-05-28
EP1229965B1 (de) 2005-07-20

Similar Documents

Publication Publication Date Title
IL156618A0 (en) Crystals of whole antibodies and fragments thereof, methods for the preparation thereof and diagnostic kits utilizing the same
ES2293973T3 (es) Anticuerpos anti-ccr2 humanizados y metodos de uso de los mismos.
TR200002731T2 (tr) Proteolitik antikorların indüktör ve inhibitörlerinin tanımlanması, kompozisyonları ve kullanımları için metotlar
DE60226499D1 (de) Verwendung von antikörpern gegen das muc18-antigen
DE69739856D1 (de) Agonisten für den rezeptor des hepatozyten-wachstumsfaktors und deren anwendungen
CY1112507T1 (el) Μορια αντισωματος που εχουν ειδικοτητα για την ανθρωπινη ιl-1β
ATE197592T1 (de) Monoklonaler antikörper gegen cd44v6
CY1118443T1 (el) Anti-tnf αντισωματα, συνθεσεις, μεθοδοι και χρησεις
EP1470146A4 (de) Antikörper gegen das muc18?antigen
BR0114475A (pt) Célula para a produção de composição de anticorpo
TR200002284T2 (tr) Mage ailesinden tümör ile ilgili tümör türevleri
DK1053256T3 (da) Antistoffer mod Dødsreceptor 4 (DR4) og anvendelser deraf
DE60033062D1 (de) Antikörper spezifisch für dendritische zellen, zusammensetzungen und verfahren, die diese antikörper verwenden, das durch die antikörper detektierte antigen und die dadurch erhaltenen zellen
ATE517340T1 (de) Sätze gegen kurze epitope gerichteter digitaler antikörper sowie diese verwendende verfahren
ECSP088636A (es) Antígenos de ácido des-n-acetil-siálico, anticuerpos para los mismos, y métodos de uso en la terapia de cáncer
NO971341D0 (no) Promoter for reseptor tyrosinkinase TIE
ATE395363T1 (de) Monoklonale antikörper gegen das protein g3bp und deren verwendungen
WO2001057219A3 (en) Mammalian interleukin-1-delta and -epsilon. their use in therapeutic and diagnostic methods
ATE299739T1 (de) Neurokinin b vorläufer aus menschlicher plazenta
ATE277352T1 (de) Einetenascin-c isoform als marker für neoplasmen
ATE306668T1 (de) Diagnose von brustkrebs unter verwendung von bcmp-7 als marker
PT1196188E (pt) Anticorpos monoclonais selectivos para o fcv e sua utilizacao para o tratamento de doencas associadas ao fcv
EP1319089A4 (de) In vitro testverfahren zur bestimmung der immunogenizität eines impfstoffes
CY1114280T1 (el) Αντισωματα ανταγωνιστων των κυτοκινων θηλαστικων ή οι υποδοχεις τους για την αγωγη της αλλεργιας
ATE343596T1 (de) Humane monoklonale antikörper gegen inselzellantigen ia-2

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties